NJ State Employees Deferred Compensation Plan - APOLLO ENDOSURGERY INC ownership

APOLLO ENDOSURGERY INC's ticker is APEN and the CUSIP is 03767D108. A total of 33 filers reported holding APOLLO ENDOSURGERY INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of APOLLO ENDOSURGERY INC
ValueSharesWeighting
Q1 2023$1,289,600
-0.5%
130,0000.0%0.20%
-5.2%
Q4 2022$1,296,100
+81.0%
130,0000.0%0.21%
+70.7%
Q3 2022$716,000
+50.7%
130,0000.0%0.12%
+59.7%
Q2 2022$475,000
-39.6%
130,0000.0%0.08%
-27.4%
Q1 2022$787,000
-28.2%
130,0000.0%0.11%
-23.2%
Q4 2021$1,096,000
-7.0%
130,0000.0%0.14%
-13.8%
Q3 2021$1,178,000
+11.9%
130,0000.0%0.16%
+14.3%
Q2 2021$1,053,000
+47.1%
130,0000.0%0.14%
+37.3%
Q1 2021$716,000
+62.0%
130,0000.0%0.10%
+50.0%
Q4 2020$442,000
+100.9%
130,0000.0%0.07%
+70.0%
Q3 2020$220,000
+4.3%
130,0000.0%0.04%0.0%
Q2 2020$211,000
-15.6%
130,0000.0%0.04%
-29.8%
Q1 2020$250,000
-32.6%
130,0000.0%0.06%
-9.5%
Q4 2019$371,000
-14.3%
130,0000.0%0.06%
-20.3%
Q3 2019$433,000
+2.4%
130,0000.0%0.08%
+3.9%
Q2 2019$423,000
-13.0%
130,0000.0%0.08%
-13.6%
Q1 2019$486,000
+17.4%
130,000
+8.3%
0.09%
+2.3%
Q4 2018$414,000
-50.2%
120,000
+3.4%
0.09%
-39.4%
Q3 2018$832,000
-22.6%
116,000
-24.7%
0.14%
-26.0%
Q2 2018$1,075,000
+12.1%
154,000
-1.3%
0.19%
+12.3%
Q1 2018$959,000156,0000.17%
Other shareholders
APOLLO ENDOSURGERY INC shareholders Q2 2020
NameSharesValueWeighting ↓
Parian Global Management LP 820,388$7,433,0005.19%
Gagnon Advisors, LLC 1,329,354$12,044,0004.78%
Stonepine Capital Management, LLC 912,125$8,264,0003.76%
CPMG Inc 3,194,871$28,946,0003.19%
GAGNON SECURITIES LLC 1,540,928$13,961,0002.07%
Parkman Healthcare Partners LLC 831,214$7,531,0001.90%
Archon Capital Management LLC 756,154$6,851,0000.97%
Manatuck Hill Partners, LLC 238,500$2,161,0000.76%
Nantahala Capital Management 2,514,328$22,780,0000.72%
EAM Investors, LLC 209,706$1,900,0000.32%
View complete list of APOLLO ENDOSURGERY INC shareholders